U.S-CHINA TRADE TALKS BEGIN IN PARIS, SETTING STAGE FOR TRUMP-XI SUMMIT. (PHOTO).

Image
 US-China trade talks begin in Paris, setting stage for Trump-Xi summit  U.S. and Chinese officials began high-level trade talks in Paris on Sunday, setting the stage for President Donald Trump’s upcoming visit to Beijing to meet Chinese leader Xi Jinping in about two weeks. The delegations are led by U.S. Treasury Secretary Scott Bessent and Chinese Vice Premier He Lifeng. While the White House has announced Trump’s visit for March 31 to April 2, Beijing has not yet confirmed the dates. Bessent emphasized that the U.S. team aims to secure outcomes that prioritize American farmers, workers, and businesses. Over the two-day talks, the delegations will focus on trade and economic issues of mutual concern. Trump’s visit will be his first to China since his first term in 2017 and follows a one-year truce in the U.S.-China trade war agreed upon last year in Busan, South Korea. Despite the truce, tensions remain, including over a new U.S. trade investigation into 16 trading partners...

NAFDAC NOTIFIES THE PUBLIC OF FALSIFIED TYPE 1 AND TYPE 2 BATCHES OF POSTINOR-2 (LEVONORGESTREL 0.75MG) PRODUCT IN CIRCULATION. (PHOTOS). #PRESS RELEASE


 Public Alert No. 027/2025.

Alert on confirmed counterfeit Postinor-2 (Levonorgestrel 0.75mg) in Nigeria

NAFDAC notifies the public of falsified Type 1 and Type 2 batches of POSTINOR-2 (Levonorgestrel 0.75mg) product in circulation. A report was received from the Marketing Authorisation Holder @SFHNigeria confirming that they did not import the product batch in question.


Product details:

•On the fake product, the PIN verification sticker has a smaller font size and misspells “Verify” as “Veify”. The original sticker uses a larger, clearer font.

•On the fake pack, the word “Distributed in Nigeria” is wrongly spelt as “Distnibuted in Nigeria”

Risk Statement

Due to the possible presence of harmful or substandard ingredients, incorrect dosages of levonorgestrel, and unsafe manufacturing practices, falsified Postinor-2 (Levonorgestrel 0.75mg) poses serious risks to individual health and public safety.

These risks include contraceptive failure, toxic contamination, unpredictable side effects, delayed or missed access to genuine emergency contraception, and long-term reproductive health complications.

Counterfeit medicines may also contain unknown substances that can cause allergic reactions, organ damage, or even death. Patients are strongly advised to obtain Postinor-2 only from verified pharmacies or licensed healthcare providers.

Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322 or send an email to sf.alert@nafdac.gov.ng.

More photos below. 





Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

SHAKIRA COVERS WOMEN'S HEALTH MAGAZINE,APRIL ISSUE.

AMBODE,SOYINKA & OTHERS AT THE OFFICIAL LAUNCH OF LAGOS AT 50 YEARS ANNIVERSARY AGAINST 2017.{PHOTOS}.